Name - Colonnade Acquisition Corp. II
Current Name: Pluri Inc. (Successor - via cross-tracking scripts / Pluri took over core listing shell frameworks)
Address: 3300 Ponce de Leon Blvd, Coral Gables, FL 33134
Phone Number: (305) 504-3190
Investor Relations Contact: ir@colonnadeacquisition.com
Website - https://www.colonnadeacquisition.com
Warrant Symbol: CLAA.WS / CLAAW
Warrants Listed: 11,500,000
Ratio: 1-for-1
Cusip Number: 196850 11 9
Expiry Date - March 12, 2026
xercise Price: $11.50
Synopsis & Listing Information
Colonnade Acquisition Corp. II was a blank-check company incorporated in the Cayman Islands and led by CEO Remy W. Trafelet. The sponsor framework targeted businesses in the consumer, healthcare, or mobile technology industries.
Listing History: The company’s IPO closed on March 12, 2021. The warrants began separate trading on the NYSE under the symbols CLAA.WS and CLAAW shortly thereafter.
Business Combination: N/A. The company entered deep preliminary diligence cycles with multiple high-growth software and bio-tech operators, but could not finalize an asset merger within its timeline boundaries.
Ticker Change: N/A.
Reverse Split Adjustment: N/A.
Current Status: Liquidated. On March 12, 2026, Colonnade Acquisition Corp. II completely wound down its operations due to the expiration of its operational corporate life cycle. The common trust shares were redeemed, and the public warrants under CUSIP 196850 11 9 expired completely worthless.
Current Name: Pluri Inc. (Successor - via cross-tracking scripts / Pluri took over core listing shell frameworks)
Address: 3300 Ponce de Leon Blvd, Coral Gables, FL 33134
Phone Number: (305) 504-3190
Investor Relations Contact: ir@colonnadeacquisition.com
Website - https://www.colonnadeacquisition.com
Warrant Symbol: CLAA.WS / CLAAW
Warrants Listed: 11,500,000
Ratio: 1-for-1
Cusip Number: 196850 11 9
Expiry Date - March 12, 2026
xercise Price: $11.50
Synopsis & Listing Information
Colonnade Acquisition Corp. II was a blank-check company incorporated in the Cayman Islands and led by CEO Remy W. Trafelet. The sponsor framework targeted businesses in the consumer, healthcare, or mobile technology industries.
Listing History: The company’s IPO closed on March 12, 2021. The warrants began separate trading on the NYSE under the symbols CLAA.WS and CLAAW shortly thereafter.
Business Combination: N/A. The company entered deep preliminary diligence cycles with multiple high-growth software and bio-tech operators, but could not finalize an asset merger within its timeline boundaries.
Ticker Change: N/A.
Reverse Split Adjustment: N/A.
Current Status: Liquidated. On March 12, 2026, Colonnade Acquisition Corp. II completely wound down its operations due to the expiration of its operational corporate life cycle. The common trust shares were redeemed, and the public warrants under CUSIP 196850 11 9 expired completely worthless.
American Financial News
Loading the latest American market news...
American Financial News
Loading the latest American market news...